Corcept Therapeutics (CORT) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $118.10 +0.79%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
PODC, CLIR, ARDS, More
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
PODC, CLIR, ARDS, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q3 EPS of ($0.01), $0.01 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $13.3 million versus the consensus estimate of $13.9 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Assumes Corcept Therapeutics (CORT) at Buy
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Prenetics Global (PRE) Tops Q2 EPS by 18c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
